Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.

Oncology reports - 1 Nov 2004

Wu Chi-Ming, Tang Reiping, Chen Jim-Ray, Wu Meng-Chih, Chien Huei-Tzu, Changchien Chung Rong, Hsieh Ling-Ling

Abstract excerpt

To explore the relationship between mutations of the p53 gene, p53 protein accumulation in tumor tissues and the presence of anti-p53 antibodies (Ab) in sera, a matched case-control study with 63 colorectal cancer patients positive for p53-Ab was carried out. These control patients were matched for age, gender, as well as tumor site and stage with 63 colorectal cancer patients positive for p53-Ab. The study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antibodies, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Conserved Sequence

Share to Enzyme-Linked Immunosorbent Assay

Share to Genes, p53

Share to Immunoenzyme Techniques

Share to Polymorphism, Single-Stranded Conformational

Share to Taiwan

Source

Identifiers

PMID: 15492791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.PMID 15492791Read ↗

Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.Semantic proximity Read ↗

Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.Semantic proximity Read ↗

p53 genetic alterations, protein expression and autoantibodies in human colorectal carcinoma: A comparative study.Semantic proximity Read ↗

Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India.Semantic proximity Read ↗

Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.Semantic proximity Read ↗

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.Semantic proximity Read ↗

Idiotypic immunization induces immunity to mutated p53 and tumor rejection.Semantic proximity Read ↗

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.Semantic proximity Read ↗

Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.Semantic proximity Read ↗

Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Serum p53 antibodies as early markers of lung cancer.Semantic proximity Read ↗

Prevalence and clinical relevance of serum anti-p53 antibodies in patients with cholangiocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.